Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Revisiting systemic therapy in HNSCC in the era of immunotherapy

Revisiting systemic therapy in HNSCC in the era of immunotherapy - New data from randomised studies in recurrent metastatic setting

Date

21 Oct 2018

Session

Revisiting systemic therapy in HNSCC in the era of immunotherapy

Topics

Immunotherapy

Tumour Site

Head and Neck Cancers

Presenters

Marco Merlano

Authors

M.C. Merlano

Author affiliations

  • Clinical Oncology, Azienda Ospedaliera St. Croce e Carle, 12100 - Cuneo/IT
More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.